CELLMID LTD.
The Company, through its wholly owned subsidiaries Lyramid, Kinera, and Advangen, develops and markets innovative novel therapies and diagnostic tests for inflammatory and fibrotic diseases, cancer, ischemic diseases of the heart, and hair loss. Cellmid holds the largest and most comprehensive portfolio of intellectual property relating to the novel targets midkine (MK) and FGF5 globally.
CELLMID LTD.
Industry:
Biotechnology Health Care Therapeutics
Address:
Sydney, New South Wales, Australia
Country:
Australia
Website Url:
http://www.cellmid.com.au
Status:
Active
Contact:
+61 2 9221 6830
Technology used in webpage:
SPF Domain Not Resolving Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail Pound Sterling Japanese Yen CPanel Barracuda Networks Thickbox
Similar Organizations
Cell Care
Cell Care is most experienced cord blood and tissue bank.
Official Site Inspections
http://www.cellmid.com.au
- Host name: vmres07.auserver.com.au
- IP address: 101.0.117.10
- Location: Australia
- Latitude: -33.494
- Longitude: 143.2104
- Timezone: Australia/Sydney
Loading ... 